RYAN SPECIALTY HOLDINGS INC
RYANNYSE🏆 #1336 by market capEarnings Oct 29 · PostUS Equity
$37.85▼ $0.27 (−0.71%)
Market closed · at closeTrack RYAN
Get earnings, price moves & breaking news on Telegram
24h▼ 0.7%
7d▲ 4.7%
14d▼ 6.0%
30d▼ 10.3%
ytd▼ 26.7%
1y▼ 32.8%
🏦Market Cap
$4.90B
Small Cap
📈Revenue Growth (YoY)
+21.3%
Healthy
📊Gross Margin
81.1%
High
💵FCF Margin
15.4%
Healthy
⚖️P/S Ratio
1.5x
Cheap
Otter Score
80
Good
RYAN SPECIALTY HOLDINGS INC
RYANAnalyst Ratings
Price
$37.85
Total
19
Raised
0
Lowered
2
Avg PT
$47.78
H / L
$69 / $31
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Mizuho | Reiterated | Neutral | 2026-09-16 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-08-19 | $50.00 | +32.10% |
Cantor Fitzgerald | Reiterated | Neutral | 2026-08-03 | $41.00 | +8.30% |
JP Morgan | Reiterated | Underweight | 2026-08-03 | — | — |
UBS | Reiterated | Buy | 2026-08-03 | $55.00 | +45.30% |
Wells Fargo | Reiterated | Equal Weight | 2026-08-03 | $31.00 | −18.10% |
Citigroup | Reiterated | Buy | 2026-08-03 | $42.00 | +11.00% |
Keefe, Bruyette & Woods | Reiterated | Outperform | 2026-07-31 | — | — |
Barclays | Reiterated | Overweight | 2026-07-31 | $48.00 | +26.80% |
RBC Capital | Reiterated | Outperform | 2026-07-31 | $55.00 | +45.30% |
Goldman Sachs | Reiterated | Neutral | 2026-07-31 | $45.00 | +18.90% |
Piper Sandler | Reiterated | Neutral | 2026-07-31 | $48.00 | +26.80% |
B of A Securities | Reiterated | Buy | 2026-04-14 | — | — |
BMO Capital | Downgraded | Outperform → Market Perform | 2026-02-25 | $66.00 | +74.40% |
TD Cowen | Reiterated | Buy | 2025-11-26 | — | — |
Citizens Capital Markets | Reiterated | Market Perform | 2025-02-21 | — | — |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2024-05-06 | — | — |
Autonomous Research | Reiterated | Underperform | 2023-02-21 | — | — |
William Blair | Reiterated | Outperform | 2021-08-20 | — | — |
Institution
Mizuho
Reiterated · Neutral · 2026-09-16
—
—
Morgan Stanley
Reiterated · Overweight · 2026-08-19
$50.00
+32.10%
Cantor Fitzgerald
Reiterated · Neutral · 2026-08-03
$41.00
+8.30%
JP Morgan
Reiterated · Underweight · 2026-08-03
—
—
UBS
Reiterated · Buy · 2026-08-03
$55.00
+45.30%
Wells Fargo
Reiterated · Equal Weight · 2026-08-03
$31.00
−18.10%
Citigroup
Reiterated · Buy · 2026-08-03
$42.00
+11.00%
Keefe, Bruyette & Woods
Reiterated · Outperform · 2026-07-31
—
—
Barclays
Reiterated · Overweight · 2026-07-31
$48.00
+26.80%
RBC Capital
Reiterated · Outperform · 2026-07-31
$55.00
+45.30%
Goldman Sachs
Reiterated · Neutral · 2026-07-31
$45.00
+18.90%
Piper Sandler
Reiterated · Neutral · 2026-07-31
$48.00
+26.80%
B of A Securities
Reiterated · Buy · 2026-04-14
—
—
BMO Capital
Downgraded · Outperform → Market Perform · 2026-02-25
$66.00
+74.40%
TD Cowen
Reiterated · Buy · 2025-11-26
—
—
Citizens Capital Markets
Reiterated · Market Perform · 2025-02-21
—
—
Wolfe Research
Downgraded · Outperform → Peer Perform · 2024-05-06
—
—
Autonomous Research
Reiterated · Underperform · 2023-02-21
—
—
William Blair
Reiterated · Outperform · 2021-08-20
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space